Sanofi to Transfer U.S. Stock Exchange Listing to Nasdaq

Sanofi announced that it will be transferring the listing of its American Depositary Shares (ADS) from the New York Stock...

GW Pharmaceuticals Announces the Closing of Public Offering of ADSs

GW Pharmaceuticals (Nasdaq:GWPH), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform,...

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.

5 Top NASDAQ Biotech Stocks: Second Sight Medical on Top

Second Sight, Juniper, Athersys, Aptose and ArQule were last week's five top-gaining NASDAQ biotech stocks. See what moved their share...

5 Top NASDAQ Biotech Stocks: Tenax on top with a 51.94 Percent Increase

This past week the NASDAQ Biotechnology Index increased by 4.15 percent reaching 3,501.80 points in the last week—nearly equal to...

Ascendis Pharma Announces Proposed Public Offering of ADSs

Ascendis Pharma (Nasdaq:ASND), a clinical stage biopharmaceutical company, announced that it has commenced an underwritten public offering of $150,000,000 of American Depositary...